Purchase Order 75N91023P00676

Award Date 8/1/23
Potential Completion Date 9/24/23
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $13,790 firm fixed price delivery order to Illumina, Inc. for biological kits. The award was issued under an unspecified governmentwide acquisition contract vehicle. The prime contractor Illumina will provide the kits to support the National Cancer Institute's research efforts. The place of performance is Illumina's facility in San Diego, California. The period of performance is one...
The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, has awarded a $19,240 firm fixed price delivery order contract to Illumina, Inc. of San Diego, California. The contract is for supplies to support the agency's biomedical research mission. Illumina will provide products under the contract through December 2023 to assist NCI in advancing its goals of understanding, detecting and treating cancer through research. No...
The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $60,305.60 firm fixed price delivery order to Illumina, Inc. for reagents and consumables. The place of performance will be Illumina's facilities located in San Diego, California. The period of performance is one month, from July 31, 2023 through August 30, 2023. No set aside designation or subcontractors were identified. This delivery order is likely in support of the...
The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $93,969.03 firm fixed price delivery order contract to Illumina, Inc. for reagents and consumables. The place of performance will be Illumina's facilities located in San Diego, California. The period of performance is from December 20, 2023 through January 19, 2024. This delivery order was awarded under an existing government-wide acquisition contract vehicle or blanket...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $113,775 delivery order contract to Illumina, Inc. of San Diego, California. Under the terms of the firm fixed price delivery order, Illumina will provide biological kits to support the NIH NCI's research efforts. As a leading biotechnology company, Illumina is well positioned to meet the needs of this customer for such laboratory materials. No subcontractors or set aside designations...
The National Institutes of Health National Cancer Institute awarded a $10,156 delivery order contract to Illumina, Inc. of San Diego, California. Under the terms of the firm fixed price award, Illumina will provide biological materials to support the agency's research efforts. The contract runs from August 2023 to January 2024 and utilizes the NIH's Scientific Management Review Board vehicle to acquire the needed products and services. No set aside provisions or subcontractors were identified....
The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $25,731 delivery order contract to Illumina, Inc. of San Diego, California. Under the terms of the firm fixed price delivery order, Illumina will provide reagents and consumables to the NCI in support of its biomedical research efforts. The one month period of performance extends from August 13th to September 12th, 2023. No subcontractors or set aside designations were...
The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $146,062.52 firm fixed price delivery order to Illumina, Inc. for reagents and consumables. The place of performance is San Diego, California. The period of performance is from August 15, 2023 through September 14, 2023. No set aside designation or subcontractors were identified. The award will provide reagents and consumables to support the NCI's biomedical research...
The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $186,847 delivery order contract to Illumina, Inc. of San Diego, California. Under the terms of the firm fixed price delivery order, Illumina will provide reagents and consumables to the NCI in support of its biomedical research efforts. The one month period of performance extends from August 10th to September 9th, 2023. No subcontractors or set aside designations were...
The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $201,338 delivery order to Illumina, Inc. for reagents and consumables. The firm fixed price order is being performed in San Diego, California under the prime contractor's base indefinite-delivery/indefinite-quantity contract vehicle with the agency. Illumina will provide the requested products to support the NCI's biomedical research efforts from November 15th to...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $20,381.70 firm fixed price purchase order to Illumina, Inc. for unspecified products or services. The place of performance will be in Bethesda, Maryland through September 2023. Illumina will deliver the requested items or work to support the National Cancer Institute, part of the NIH focused on cancer research, treatment, and initiatives to reduce the public health burden of cancer. No major subcontractors or additional award details were provided in the information given.

Generated 12/15/23, 1:16 PM